Cargando…
The proto-oncogene KRAS is targeted by miR-200c
The GTPase K-ras is involved in a variety of cellular processes such as differentiation, proliferation and survival. However, activating mutations, which frequently occur in many types of cancer, turn KRAS into one of the most prominent oncogenes. Likewise, miR-200c is a key player in tumorigenesis...
Autores principales: | Kopp, Florian, Wagner, Ernst, Roidl, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960200/ https://www.ncbi.nlm.nih.gov/pubmed/24368337 |
Ejemplares similares
-
miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression
por: Kopp, Florian, et al.
Publicado: (2012) -
A proteomic analysis of an in vitro knock-out of miR-200c
por: Ljepoja, Bojan, et al.
Publicado: (2018) -
miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS
por: Neu, Johannes, et al.
Publicado: (2017) -
miR-200c inhibits breast cancer proliferation by targeting KRAS
por: Song, Cailu, et al.
Publicado: (2015) -
An Immunocompetent Environment Unravels the Proto-Oncogenic Role of miR-22
por: Centomo, Maria Laura, et al.
Publicado: (2022)